Abstract
Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) near the human leukocyte antigen (HLA)-DP loci that were significantly correlated with outcomes of hepatitis B virus (HBV) infection. We performed a case–control study nested in a well-characterized cohort of booster recipients to assess whether genetic variants of HLA-DPB1 are also associated with response to hepatitis B (HB) vaccination. The cases and controls were 171 and 510 booster recipients whose post-booster titers of antibodies against HBV surface antigen (anti-HBs) were undetectable and detectable, respectively. The HLA-DPB1 genotype was determined using sequence-based techniques. The frequencies of HLA-DPB1 alleles were significantly different between cases and controls (p = 1.7 × 10−8). The HLA-DPB1 05:01 and 09:01 alleles were significantly more frequent in the cases, and 02:01:02, 02:02, 03:01:01, 04:01:01, and 14:01, were significantly more frequent in the controls. The adjusted odds ratio (OR) of undetectable post-booster anti-HBs titers was significantly correlated with the number of risk alleles (p for trend = 3.8 × 10−5). For the number of protective alleles, the trend was significantly inversed (p for trend = 1.3 × 10−5). As compared with subjects with two risk alleles, adjusted OR were 0.34 (95 % confidence interval [CI] 0.21–0.55) and 0.20 (95 % CI 0.08–0.48) for subjects with 1 and 2 protective alleles, respectively. The HLA-DPB1 02:02, 04:01:01, 05:01 and 09:01 alleles were also significantly correlated with the likelihoods of undetectable pre-booster anti-HBs titers. Our results indicated that HLA-DPB1 is significantly correlated with response to booster HB vaccination in adolescent who had received postnatal active HB vaccination. HLA-DBP1 may also determine the long-term persistence of response to HB vaccination.
Similar content being viewed by others
Abbreviations
- Anti-HBs:
-
Antibodies to hepatitis B surface antigen
- Anti-HBc:
-
Antibodies to hepatitis B core antigen
- CI:
-
Confidence interval
- HB:
-
Hepatitis B
- HBIG:
-
Hepatitis B immunoglobin
- HBeAg:
-
Hepatitis B e antigen
- HBsAg:
-
Hepatitis B surface antigen
- HBV:
-
Hepatitis B virus
- HLA:
-
Human leukocyte antigens
- OR:
-
Odds ratio
References
Amanna IJ, Slifka MK (2011) Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 411:206–215
Blackwell JM, Jamieson SE, Burgner D (2009) HLA and infectious diseases. Clin Microbiol Rev 22:370–385
Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, Kuo YT, Lo KJ, Shih YT (1987) A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257:2597–2603
Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS (1996) Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 276:906–908
Davenport MP, Hill AV (1996) Reverse immunogenetics: from HLA-disease associations to vaccine candidates. Mol Med Today 2:38–45
Desombere I, Willems A, Leroux-Roels G (1998) Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 51:593–604
El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264–1273
Fattovich G, Bortolotti F, Donato F (2008) Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 48:335–352
Ganem D, Prince AM (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350:1118–1129
Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O’Brien SJ (2011) Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 53:422–428
Hatae K, Kimura A, Okubo R, Watanabe H, Erlich HA, Ueda K, Nishimura Y, Sasazuki T (1992) Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype. Eur J Immunol 22:1899–1905
Hsu HY, Chang MH, Ho HN, Hsieh RP, Lee SD, Chen DS, Lee CY, Hsieh KH (1993) Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. Vaccine 11:1437–1440
Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS (1999) Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 179:367–370
Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, Huang LM, Chen CJ, Chen DS (2010) Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 51:1547–1554
Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H, Puseenam A, Sura T, Daigo Y, Chayama K, Chantratita W, Nakamura Y, Matsuda K (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41:591–595
Li J, Yang D, He Y, Wang M, Wen Z, Liu L, Yao J, Matsuda K, Nakamura Y, Yu J, Jiang X, Sun S, Liu Q, Jiang X, Song Q, Chen M, Yang H, Tang F, Hu X, Wang J, Chang Y, He X, Chen Y, Lin J (2011) Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case–control study. PLoS ONE 6:e24221
Liang TJ (2009) Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13–S21
Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, Chiang YM, Liu TT, Chen CL (2003) Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 69:471–474
Lin HH, Chang Liao HW, Lin SK, Wang LY (2008) HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. Vaccine 26:3414–3420
Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, Twu SJ, Su IJ, Huang LM, Lee CY (2004) Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 40:1415–1420
Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD, Hung CH, Lee CM, Changchien CS (2006) Hepatitis B virus infection in adolescents in a rural township-15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 24:759–765
Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Fernandez-Vina M, Geraghty DE, Holdsworth R, Hurley CK, Lau M, Lee KW, Mach B, Maiers M, Mayr WR, Muller CR, Parham P, Petersdorf EW, Sasazuki T, Strominger JL, Svejgaard A, Terasaki PI, Tiercy JM, Trowsdale J (2010) Nomenclature for factors of the HLA system, 2010. Tissue Antigens 75:291–455
Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A, Salvaneschi L, Rondini G, Avanzini MA, Cuccia M (2000) Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 97:234–240
McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA (1997) Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 50:8–14
McMahon BJ (2009) The natural history of chronic hepatitis B virus infection. Hepatology 49(5 Suppl):S45–S55
Naruse TK, Nose Y, Kagiya M, Liao G, Nabeya N, Kimura M, Isshiki G, Inoko H (1995) Cloned primed lymphocyte test cells recognize the fourth, fifth, and sixth hypervariable regions at amino acid positions 65–87 of the DPB1 molecule. Hum Immunol 42:123–130
Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, Marchant A (2004) Genetic regulation of immune responses to vaccines in early life. Genes Immun 5:122–129
Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, Hige S, Kang JH, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M (2012) Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS ONE 7:e39175
Rehermann B, Nascimbeni M (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5:215–229
Tangye SG (2011) Staying alive: regulation of plasma cell survival. Trends Immunol 32:595–602
van der Zwan A, Rozemuller E, Tilanus M (2006) Sequencing based typing for HLA-DPB1: Strategy for ABI equipment. IHWG Press, Seattle
Varla-Leftherioti M, Papanicolaou M, Spyropoulou M, Vallindra H, Tsiroyianni P, Tassopoulos N, Kapasouri H, Stavropoulos-Giokas C (1990) HLA-associated non-responsiveness to hepatitis B vaccine. Tissue Antigens 35:60–63
Versluis LF, Rozemuller EH, Duran K, Tilanus MGJ (1995) Ambiguous DPB1 allele combinations resolved by direct sequencing of selectively amplified alleles. Tissue Antigens 46:345–349
Wang LY, Lin HH (2007) Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. J Hepatol 46:1018–1025
Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, Li YP, Tian Y, Li RC, Li Z, Zhu X, Li JH, Cai J, Liu L, Miao XP, Liu Y, Li H (2011) Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS ONE 6:e17608
Wu JS, Hwang LY, Goodman KJ, Beasley RP (1999) Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 179:1319–1325
Wu TW, Lin HH, Wang LY (2013) Chronic hepatitis B infection in adolescents who had received primary infantile vaccination. Hepatology 57:38–45
Zino E, Frumento G, Marktel S, Sormani MP, Ficara F, Di Terlizzi S, Parodi AM, Sergeant R, Martinetti M, Bontadini A, Bonifazi F, Lisini D, Mazzi B, Rossini S, Servida P, Ciceri F, Bonini C, Lanino E, Bandini G, Locatelli F, Apperley J, Bacigalupo A, Ferrara GB, Bordignon C, Fleischhauer K (2004) A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 103:1417–1424
Acknowledgments
We thank to the staffs of the senior high schools and health stations in Hualien County and the Center of Disease Control, Department of Health, Taiwan, for their valuable contribution. This research was supported by grants from Mackay Medical College (981B03 & 991A01) and the National Science Council, Taiwan (NSC97-2314-B-715-001-MY3). The funding agencies played no role in the work.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
T.-W. Wu and C.-C. Chu contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wu, TW., Chu, CC., Ho, TY. et al. Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents. Hum Genet 132, 1131–1139 (2013). https://doi.org/10.1007/s00439-013-1320-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-013-1320-5